Jaffetilchin Investment Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-12,613
| Closed | -$1M | – | 475 |
|
|
2025
Q4 | $1M | Buy |
12,613
+5,704
| +83% | +$450K | 0.06% | 190 |
|
|
2025
Q3 | $521K | Buy |
+6,909
| New | +$473K | 0.03% | 276 |
|
|
2024
Q4 | – | Sell |
-1,298
| Closed | -$81.6K | – | 569 |
|
|
2024
Q3 | $81.6K | Sell |
1,298
-7,359
| -85% | -$429K | 0.01% | 496 |
|
|
2024
Q2 | $511K | Buy |
8,657
+2,155
| +33% | +$135K | 0.04% | 211 |
|
|
2024
Q1 | $519K | Sell |
6,502
-911
| -12% | -$69.6K | 0.05% | 205 |
|
|
2023
Q4 | $585K | Sell |
7,413
-5,126
| -41% | -$365K | 0.06% | 196 |
|
|
2023
Q3 | $875K | Buy |
+12,539
| New | +$888K | 0.1% | 127 |
|
|
2023
Q2 | – | Sell |
-7,808
| Closed | -$580K | – | 362 |
|
|
2023
Q1 | $580K | Sell |
7,808
-2,288
| -23% | -$192K | 0.07% | 178 |
|
|
2022
Q4 | $941K | Sell |
10,096
-1,175
| -10% | -$113K | 0.11% | 136 |
|
|
2022
Q3 | $1.07M | Sell |
11,271
-403
| -3% | -$39.9K | 0.14% | 99 |
|
|
2022
Q2 | $1.08M | Sell |
11,674
-2,572
| -18% | -$251K | 0.13% | 113 |
|
|
2022
Q1 | $1.4M | Sell |
14,246
-4,330
| -23% | -$455K | 0.16% | 86 |
|
|
2021
Q4 | $1.92M | Sell |
18,576
-429
| -2% | -$39.6K | 0.18% | 86 |
|
|
2021
Q3 | $1.61M | Sell |
19,005
-32
| -0.2% | -$2.68K | 0.17% | 92 |
|
|
2021
Q2 | $1.59M | Sell |
19,037
-3,949
| -17% | -$323K | 0.11% | 135 |
|
|
2021
Q1 | $1.73M | Sell |
22,986
-489
| -2% | -$35.6K | 0.2% | 91 |
|
|
2020
Q4 | $1.6M | Sell |
23,475
-85
| -0.4% | -$5.53K | 0.23% | 76 |
|
|
2020
Q3 | $1.38M | Buy |
23,560
+7,119
| +43% | +$443K | 0.25% | 60 |
|
|
2020
Q2 | $1.07M | Buy |
+16,441
| New | +$1.04M | 0.24% | 61 |
|
|
2019
Q4 | – | Sell |
-3,816
| Closed | -$241K | – | 228 |
|
|
2019
Q3 | $241K | Sell |
3,816
-13,390
| -78% | -$793K | 0.06% | 191 |
|
|
2019
Q2 | $938K | Buy |
17,206
+7,769
| +82% | +$418K | 0.22% | 74 |
|
|
2019
Q1 | $509K | Sell |
9,437
-3,430
| -27% | -$212K | 0.11% | 157 |
|
|
2018
Q4 | $843K | Buy |
+12,867
| New | +$960K | 0.21% | 67 |
|
|
2016
Q4 | – | Sell |
-2,294
| Closed | -$204K | – | 258 |
|
|
2016
Q3 | $204K | Sell |
2,294
-75
| -3% | -$7.08K | 0.06% | 208 |
|
|
2016
Q2 | $227K | Sell |
2,369
-6
| -0.3% | -$598 | 0.07% | 196 |
|
|
2016
Q1 | $246K | Sell |
2,375
-4,067
| -63% | -$395K | 0.08% | 148 |
|
|
2015
Q4 | $630K | Buy |
6,442
+589
| +10% | +$57.7K | 0.2% | 78 |
|
|
2015
Q3 | $565K | Sell |
5,853
-2,564
| -30% | -$270K | 0.21% | 82 |
|
|
2015
Q2 | $883K | Buy |
8,417
+5,801
| +222% | +$593K | 0.26% | 62 |
|
|
2015
Q1 | $270K | Sell |
2,616
-601
| -19% | -$60.8K | 0.08% | 173 |
|
|
2014
Q4 | $310K | Sell |
3,217
-34
| -1% | -$3K | 0.1% | 166 |
|
|
2014
Q3 | $259K | Sell |
3,251
-4,999
| -61% | -$394K | 0.1% | 168 |
|
|
2014
Q2 | $622K | Buy |
8,250
+4,997
| +154% | +$378K | 0.22% | 75 |
|
|
2014
Q1 | $244K | Sell |
3,253
-4,918
| -60% | -$347K | 0.1% | 161 |
|
|
2013
Q4 | $585K | Buy |
8,171
+4,325
| +112% | +$278K | 0.29% | 80 |
|
|
2013
Q3 | $218K | Sell |
3,846
-4,554
| -54% | -$271K | 0.13% | 159 |
|
|
2013
Q2 | $480K | Buy |
+8,400
| New | +$487K | 0.33% | 83 |
|
Other funds holding CVS
VCM
VPM
Jaffetilchin Investment Partners's CVS Position: Q1 2026 in Review
Jaffetilchin Investment Partners sold out of CVS Health (CVS) in Q1 2026, closing a stake of 12,613 shares — an estimated $1M sold.
Jaffetilchin Investment Partners first reported a position in CVS in Q2 2013 and held it in 37 quarters. The position peaked at $1.92M in Q4 2021. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Jaffetilchin Investment Partners reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
- Jaffetilchin Investment Partners sold 12,613 CVS Health shares in Q1 2026, an estimated $1M.
- Jaffetilchin Investment Partners first reported a position in CVS Health in Q2 2013 and held it in 37 quarters.
- Jaffetilchin Investment Partners's CVS Health position peaked at $1.92M in Q4 2021.
- 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Jaffetilchin Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.